When taken in an adequate dose, disulfiram usually deters the drinking of a
lcohol by the threat or experience of an unpleasant reaction. However, unle
ss its consumption is carefully supervised by a third party as part of the
formal or im-plied therapeutic contract, it is usually discontinued and the
deterrent effect is therefore lost. In most studies, disulfiram administra
tion has not been supervised and most reviews fail to stress the crucial im
portance of supervision. Unsupervised disulfiram has little or no specific
effect. We have therefore reviewed all published clinical studies in which
there was evidence that attempts had been made to ensure that disulfiram ad
ministration was directly supervised at least once a week. We found 13 cont
rolled and 5 uncontrolled studies. All but one study reported positive find
ings, which were usually both statistically and clinically significant in c
ontrolled evaluations. In the sole exception, involving 'skid-row alcoholic
s', it seems that adequate supervision was not achieved. In general, the be
tter the supervision, the better the outcome.
Provided that attention is paid to the details of supervision and that supe
rvisors are given appropriate training, supervised disulfiram is a simple a
nd effective addition to psychosocial treatment programmes. Compared with u
nsupervised disulfiram or no disulfiram control groups, it reduces drinking
, prolongs remissions, improves treatment retention and facilitates complia
nce with psychosocial interventions such as community reinforcement, marita
l and network therapies. The supervisor may be a health professional, workm
ate, probation officer or hostel worker but is usually a family member. Tre
atment should probably continue for a minimum of 12 months. Supervised disu
lfiram appears to be more effective than supervised naltrexone and may be m
ore effective than unsupervised acamprosate. The crucial importance of supe
rvising the consumption of disulfiram has been overlooked or minimised by m
any reviewers.